DE60237509D1 - Gen zum nachweis von patienten mit familiärer dysautonomie - Google Patents

Gen zum nachweis von patienten mit familiärer dysautonomie

Info

Publication number
DE60237509D1
DE60237509D1 DE60237509T DE60237509T DE60237509D1 DE 60237509 D1 DE60237509 D1 DE 60237509D1 DE 60237509 T DE60237509 T DE 60237509T DE 60237509 T DE60237509 T DE 60237509T DE 60237509 D1 DE60237509 D1 DE 60237509D1
Authority
DE
Germany
Prior art keywords
mutation
haplotype
patients
gene
exon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60237509T
Other languages
English (en)
Inventor
Susan Slaugenhaupt
James F Gusella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22987684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60237509(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE60237509D1 publication Critical patent/DE60237509D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60237509T 2001-01-06 2002-01-07 Gen zum nachweis von patienten mit familiärer dysautonomie Expired - Lifetime DE60237509D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26008001P 2001-01-06 2001-01-06
PCT/US2002/000473 WO2002059381A2 (en) 2001-01-06 2002-01-07 Gene for identifying individuals with familial dysautonomia

Publications (1)

Publication Number Publication Date
DE60237509D1 true DE60237509D1 (de) 2010-10-14

Family

ID=22987684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60237509T Expired - Lifetime DE60237509D1 (de) 2001-01-06 2002-01-07 Gen zum nachweis von patienten mit familiärer dysautonomie

Country Status (8)

Country Link
US (5) US7388093B2 (de)
EP (1) EP1373568B1 (de)
AT (1) ATE479773T1 (de)
CA (1) CA2433869C (de)
DE (1) DE60237509D1 (de)
HK (1) HK1061702A1 (de)
IL (2) IL156752A0 (de)
WO (1) WO2002059381A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7388093B2 (en) 2001-01-06 2008-06-17 The General Hospital Corporation Gene for identifying individuals with familial dysautonomia
US20190276891A1 (en) * 2001-01-06 2019-09-12 The General Hospital Corporation Gene for identifying individuals with familial dysautonomia
IL142015A0 (en) * 2001-01-17 2002-03-10 Detection of mutations in a gene encoding 1kb kinase-complex-associated protein to diagnose familial dysautonomia
AU2004278773B2 (en) 2003-10-03 2011-05-19 The General Hospital Corporation Methods for altering mRNA splicing and treating familial dysautonomia and other mechanistically related disorders
CA2563087A1 (en) * 2004-04-09 2005-12-15 Ronald S. Goldstein Methods for generating neuronal cells from human embryonic stem cells and uses thereof
WO2013106770A1 (en) * 2012-01-11 2013-07-18 Isis Pharmaceuticals, Inc. Compositions and methods for modulation of ikbkap splicing

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217863A (en) * 1988-02-04 1993-06-08 Medical Research Council Detection of mutations in nucleic acids
US5387506A (en) 1992-05-29 1995-02-07 The General Hospital Corporation Use of genetic markers to diagnose familial dysautonomia
AU4390293A (en) 1992-05-29 1993-12-30 General Hospital Corporation, The Use of genetic markers to diagnose familial dysautonomia
FR2722295B1 (fr) 1994-07-07 1996-10-04 Roussy Inst Gustave Methode d'analyse d'adn dite sscp et gel d'electro-phorene
US5597898A (en) * 1995-02-15 1997-01-28 Yale University NF-κB activation regulatory protein, IκB-β
US5968740A (en) * 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
MX9802356A (es) * 1995-09-26 1998-07-31 Univ Washington Glicoproteina b de la subfamilia rfhv/kshv de virus de herpes.
US6183952B1 (en) * 1996-08-19 2001-02-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US5891719A (en) * 1997-11-16 1999-04-06 Tularik Inc. IKAP nucleic acids
EP1053352B1 (de) * 1998-02-04 2002-09-18 Variagenics, Inc. Techniken zu detektion von fehlpaarungen
IL151769A0 (en) 2000-03-15 2003-04-10 Gen Hospital Corp Use of genetic markers to diagnose familial dysautonomia
US7388093B2 (en) * 2001-01-06 2008-06-17 The General Hospital Corporation Gene for identifying individuals with familial dysautonomia
US20030092019A1 (en) 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
IL142015A0 (en) 2001-01-17 2002-03-10 Detection of mutations in a gene encoding 1kb kinase-complex-associated protein to diagnose familial dysautonomia

Also Published As

Publication number Publication date
US20050204409A1 (en) 2005-09-15
WO2002059381A3 (en) 2003-10-09
IL156752A0 (en) 2004-02-08
CA2433869A1 (en) 2002-08-01
WO2002059381A2 (en) 2002-08-01
ATE479773T1 (de) 2010-09-15
US7388093B2 (en) 2008-06-17
US20160265052A1 (en) 2016-09-15
HK1061702A1 (en) 2004-09-30
US20020169299A1 (en) 2002-11-14
US20130066060A1 (en) 2013-03-14
CA2433869C (en) 2015-11-24
US20090176222A1 (en) 2009-07-09
EP1373568A2 (de) 2004-01-02
US7407756B2 (en) 2008-08-05
EP1373568B1 (de) 2010-09-01
IL156752A (en) 2013-08-29

Similar Documents

Publication Publication Date Title
Bauwens et al. An Augmented ABCA 4 Screen Targeting Noncoding Regions Reveals a Deep Intronic Founder Variant in B elgian S targardt Patients
Rochette et al. Multicentric origin of hemochromatosis gene (HFE) mutations
Dopazo et al. 267 Spanish exomes reveal population-specific differences in disease-related genetic variation
Salisbury et al. SNP and haplotype variation in the human genome
Gilissen et al. Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome
Williams et al. Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease
Duraturo et al. Association of low‐risk MSH3 and MSH2 variant alleles with Lynch syndrome: Probability of synergistic effects
Belmouden et al. A novel frameshift founder mutation in the cytochrome P450 1B1 (CYP1B1) gene is associated with primary congenital glaucoma in Morocco
Palz et al. Clustering of mutations associated with mild Marfan‐like phenotypes in the 3′ region of FBN1 suggests a potential genotype–phenotype correlation
Symoens et al. Type I procollagen C‐propeptide defects: study of genotype–phenotype correlation and predictive role of crystal structure
Inoue et al. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement
DE60237509D1 (de) Gen zum nachweis von patienten mit familiärer dysautonomie
Tavera‐Tapia et al. RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility
Ma et al. Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease
Seddon et al. Evolutionary history of DLA class II haplotypes in canine diabetes mellitus through single nucleotide polymorphism genotyping
Hegele et al. Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency
Fuchs‐Telem et al. New intragenic and promoter region deletion mutations in FERMT1 underscore genetic homogeneity in Kindler syndrome
Borrego et al. Investigation of germline GFRA4 mutations and evaluation of the involvement of GFRA1, GFRA2, GFRA3, and GFRA4 sequence variants in Hirschsprung disease
Priyadarshi et al. Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients
Fidder et al. Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients
Västinsalo et al. Extended mutation spectrum of Usher syndrome in Finland
Park et al. The association of osteoprotegerin gene polymorphisms with periodontitis
Mukherjee et al. Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX gene
Tindale et al. Rare and common variants in the Apolipoprotein E gene in healthy oldest old
EP1255858A2 (de) Verbesserte mutationsanalyse des nf1-gens